The congenital long QT syndrome and implications for young athletes

Medicine and Science in Sports and Exercise

Volumn 38, Issue 5, 2006, Pages 816-825

  Kapetanopoulos, Athanasios ^a   Kluger, Jeffrey ^a   Maron, Barry J ^b   Thompson, Paul D ^a,c  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c HARTFORD HOSPITAL   (United States)

Author keywords

Cardiac channelopathies; Exercise; Sports participation; Sudden cardiac death

Indexed keywords

ION CHANNEL;

ATHLETE; DEFIBRILLATION; ELECTROCARDIOGRAPHY; EXERCISE; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HEART ARREST; HEART REPOLARIZATION; HIGH RISK PATIENT; HUMAN; LONG QT SYNDROME; PATHOPHYSIOLOGY; PATIENT PARTICIPATION; PREVALENCE; REVIEW; RISK FACTOR; SCREENING; SUDDEN DEATH;

ADOLESCENT; ADULT; DEATH, SUDDEN, CARDIAC; EXERCISE; FEMALE; HUMANS; LONG QT SYNDROME; MALE; SPORTS;

EID: 33646514645     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.mss.0000218130.41133.cc     Document Type: Review

References (49)

1. BENHORIN, J., R. TAUB, M. GOLDMIT, et al. Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome? Circulation 101:1698-1706, 2000.
2. CHOI, G., L. J. KOPPLIN, D. J. TESTER, M. L. WILL, C. M. HAGLUND, and M. J. ACKERMAN. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation 110:2119-2124, 2004.
3. CORRADO, D., A. PELLICCIA, H. H. BJORNSTAD, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur. Heart J. 26:516-524, 2005.
4. CORRADO, D., C. BASSO, M. SCHIAVON, and G. THIENE. Screening for hypertrophic cardiomyopathy in young athletes. N. Engl. J. Med. 339:364-369, 1998.
5. DOROSTKAR, P. C., M. ELDAR, B. BELHASSEN, and M. M. SCHEINMAN. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation 100:2431-2436, 1999.
6. ETHERIDGE, S. P., S. J. COMPTON, M. TRISTANI-FIROUZI, and J. W. MASON. A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. J. Am. Coll. Cardiol. 42:1777-1782, 2003.
7. FAGARD, R. Athlete's heart. Heart 89:1455-1456, 2003.
8. GREGORATOS, G., J. ABRAMS, A. E. EPSTEIN, et al. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. Circulation 106:2145-2161, 2002.
9. KIMBROUGH, J., A. J. MOSS, W. ZAREBA, et al. Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation 104:557-562, 2001.
10. MALIK, M., P. FARBOM, V. BATCHVAROV, K. HNATKOVA, and A. J. CAMM. Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart 87:220-228, 2002.
11. MARON, B. J. Sudden death in young athletes. N. Engl. J. Med. 349:1064-1075, 2003.
12. MARON, B. J., B. R. CHAITMAN, M. J. ACKERMAN, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 109:2807-2816, 2004.
13. MARON, B. J., P. S. DOUGLAS, T. P. GRAHAM, R. A. NISHIMURA, and P. D. THOMPSON. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J. Am. Coll. Cardiol. 45:1322-1326, 2005.
14. MARON, B. J. How should we screen competitive athletes for cardiovascular disease? Eur. Heart J. 26:428-430, 2005.
15. MITCHELL, J. H., W. HASKELL, P. SNELL, and S. P. VAN CAMP. Task Force 8: classification of sports. J. Am. Coll. Cardiol 45:1364-1367, 2005.
16. MOHLER, P. J., J. J. SCHOTT, A. O. GRAMOLINI, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421:634-639, 2003.
17. MOSS, A. J., P. J. SCHWARTZ, R. S. CRAMPTON, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 84:1136-1144, 1991.
18. MOSS, A. J., W. ZAREBA, W. J. HALL, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101:616-623, 2000.
19. MOSS, A. J., W. ZAREBA, E. S. KAUFMAN, et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105:794-799, 2002.
20. MYERBURG, R. J., N. A. ESTES, 3RD, J. M. FONTAINE, M. S. LINK, and D. P. ZIPES. Task Force 10: automated external defibrillators. J. Am. Coll. Cardiol. 45:1369-1371, 2005.
21. PELLICCIA, A., R. FAGARD, H. H. BJORNSTAD, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur. Heart J. 26:1422-1445, 2005.
22. PLASTER, N. M., R. TAWIL, M. TRISTANI-FIROUZI, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105:511-519, 2001.
23. PRIORI, S. G., P. J. SCHWARTZ, C. NAPOLITANO, et al. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 348:1866-1874, 2003.
24. PRIORI, S. G., C. NAPOLITANO, and P. J. SCHWARTZ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 99:529-533, 1999.
25. PRIORI, S. G., J. BARHANIN, R. N. HAUER, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation 99:518-528, 1999.
26. PRIORI, S. G., J. BARHANIN, R. N. HAUER, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. Circulation 99:674-681, 1999.
27. PRIORI, S. G., E. ALIOT, C. BLOMSTROM-LUNDQVIST, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur. Heart J. 22:1374-1450, 2001.
28. PRIORI, S. G., C. NAPOLITANO, P. J. SCHWARTZ, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA. 292:1341-1344, 2004.
29. SCHWARTZ, P. J., S. G. PRIORI, and C. NAPOLITANO. How really rare are rare diseases?: the intriguing case of independent compound mutations in the long QT syndrome. J. Cardiovasc. Electrophysiol. 14:1120-1121, 2003.
30. SCHWARTZ, P. J., S. G. PRIORI, C. SPAZZOLINI, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89-95, 2001.
31. SCHWARTZ, P. J., S. G. PRIORI, E. H. LOCATI, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 92:3381-3386, 1995.
32. SCHWARTZ, P. J., A. J. MOSS, G. M. VINCENT, and R. S. CRAMPTON. Diagnostic criteria for the long QT syndrome. An update. Circulation 88:782-784, 1993.
33. SCHWARTZ, P. J., S. G. PRIORI, M. CERRONE, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 109:1826-1833, 2004.
34. SHIMIZU, W., and C. ANTZELEVITCH. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation 102:706-712, 2000.
35. SHIMIZU, W., T. NODA, H. TAKAKI, et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J. Am. Coll. Cardiol. 41:633-642, 2003.
36. SPLAWSKI, I., J. SHEN, K. W. TIMOTHY, et al. Spectrum of mutations in long-QT syndrome genes. KvLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102:1178-1185, 2000.
37. SPLAWSKI, I., K. W. TIMOTHY, L. M. SHARPE, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119:19-31, 2004.
38. SWAN, H., M. VIITASALO, K. PIIPPO, P. LAITINEN, K. KONTULA, and L. TOIVONEN. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J. Am. Coll. Cardiol. 34:823-829, 1999.
39. TAKENAKA, K., T. AI, W. SHIMIZU, et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 107:838-844, 2003.
40. TRISTANI-FIROUZI, M., J. L. JENSEN, M. R. DONALDSON, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J. Clin. Invest. 10:381-388, 2002.
41. VINCENT, G. M., K. W. TIMOTHY, M. LEPPERT, and M. KEATING. The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N. Engl. J. Med. 327:846-852, 1992.
42. WESTENSKOW, P., I. SPLAWSKI, K. W. TIMOTHY, M. T. KEATING, and M. C. SANGUINETTI. Compound mutations: a common cause of severe long-QT syndrome. Circulation 109:1834-1841, 2004.
43. WILDE, A. A., R. J. JONGBLOED, P. A. DOEVENDANS, et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J. Am. Coll. Cardiol. 33:327-332, 1999.
44. ZAREBA, W., A. J. MOSS, P. J. SCHWARTZ, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N. Engl. J. Med. 339:960-965, 1998.
45. ZAREBA, W., A. J. MOSS, J. P. DAUBERT, W. J. HALL, J. L. ROBINSON, and M. ANDREWS. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J. Cardiovasc. Electrophysiol. 14:337-341, 2003.
46. ZAREBA, W., A. J. MOSS, G. SHEU, et al. Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome. J. Cardiovasc. Electrophysiol. 14:1149-1153, 2003.
47. ZHANG, L., K. W. TIMOTHY, G. M. VINCENT, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 102:2849-2855, 2000.
48. ZIPES, D. P., and J. JALIFE. Cardiac Electrophysiology. From Cell to Bedside, 3rd ed. Philadelphia, PA: WB Saunders; 2000, pp. 597-614.
49. ZIPES, D. P., M. J. ACKERMAN, N. A. ESTES, 3RD, A. O. GRANT, R. J. MYERBURG, and G. VAN HARE. Task Force 7: arrhythmias. J. Am. Coll. Cardiol. 45:1354-1363, 2005.